A Study to Evaluate Tolerability and Efficacy of Evolocumab (AMG 145) in Japanese Subjects

Clinical trial NCT01652703 · COMPLETED

Trial details

NCT number: NCT01652703
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hypercholesterolemia and High Risk for Cardiovascular Events

Start date: 2012-07-10
Primary completion: 2013-05-14
Enrollment: 310

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.